within Pharmacolibrary.Drugs.V_Various.V09X_OtherDiagnosticRadiopharmaceuticals.V09XA03_Iodine131iHumanAlbumin;

model Iodine131iHumanAlbumin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.75e-07,
    adminDuration = 600,
    adminMass = 25 / 1000000,
    adminCount = 1,
    Vd = 4.4999999999999996e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Iodine131iHumanAlbumin</td></tr><tr><td>ATC code:</td><td>V09XA03</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>25</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.045</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.15</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Iodine (131I) human albumin is a radiolabeled human albumin preparation used for diagnostic imaging, particularly for blood volume determination and radionuclide angiography. It is used in nuclear medicine to study cardiac, hepatic, and other circulatory system functions. The preparation is generally approved for clinical use in many countries, typically under regulated protocols.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult humans following intravenous administration for blood volume studies.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V09XA03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Iodine131iHumanAlbumin;
